Patent · US Active

Gemcitabine derivatives nanoparticles

US7704972B2 · kind B2 · utility

8Cited by
2References
19Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 23, 2005
Grant dateApr 27, 2010
Priority date
Expiry dateJan 23, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H19/16
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention concerns a 2′,2′-difluoro-2′-deoxycytidine derivative of general formula (I), wherein: R1, R2 and R3, identical or different, represent independently of one another, a hydrogen atom or an at least C18 hydrocarbon acyl radical and of such conformation that it is capable of providing the compound of general formula (I), a compacted form in a polar solvent medium, at least one of groups R1, R2 and R3 being other than a hydrogen atom.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.